Nitric Oxide
- Generic Name
- Nitric Oxide
- Brand Names
- Inomax, Kinox, Noxivent, INOmax
- Drug Type
- Small Molecule
- Chemical Formula
- NO
- CAS Number
- 10102-43-9
- Unique Ingredient Identifier
- 31C4KY9ESH
- Background
Nitric oxide or Nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry. It is also a toxic air pollutant produced by automobile engines and power plants.
...
- Indication
For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure
- Associated Conditions
- Hypoxic Respiratory Failure
- Associated Therapies
- -
Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)
- Conditions
- Interventions
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Dr. Denis O'Donnell
- Target Recruit Count
- 16
- Registration Number
- NCT04920695
- Locations
- 🇨🇦
Respiratory Investigation Unit, Kingston General Hospital, Kingston, Ontario, Canada
Nitric Oxide During Cardiopulmonary Bypass in Adult Surgery
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Rabin Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04807413
- Locations
- 🇮🇱
Rabin Medical Center/Beilinson Campus, Petach Tikva, Israel
Vitamin C Versus Nitric Oxide in Prolonged Ventilation
- First Posted Date
- 2020-06-02
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- King Abdul Aziz Specialist Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04411160
- Locations
- 🇸🇦
King abd el Aziz specialist hospital, Ta'if, Saudi Arabia
Inhaled Nitric Oxide for Preventing Progression in COVID-19
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Tufts Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04388683
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 21
- Registration Number
- NCT04383002
- Locations
- 🇨🇦
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT04305457
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Louisiana State University Health Shreveport, Shreveport, Louisiana, United States
🇺🇸Providence HealthCare Network, Anchorage, Alaska, United States
Pulmonary Capillary Recruitment in Fontan Patients
- Conditions
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT04292483
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
- Conditions
- Interventions
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- Xijing Hospital
- Registration Number
- NCT04290858
The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During Exercise in Hypoxia
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 20
- Registration Number
- NCT04231773
- Locations
- 🇨🇦
Clinical Physiology Laboratory, Edmonton, Alberta, Canada
NO During CPB in Neonates to Reduce Risk of AKI
- Conditions
- Interventions
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 40
- Registration Number
- NCT04216927
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.